Will biosimilar competitors increase competition, lower drug costs and knock Humira out of the top spot? We’re sharing all the facts—and some of our own predictions—in our webinar.

Will biosimilar competitors increase competition, lower drug costs and knock Humira out of the top spot? We’re sharing all the facts—and some of our own predictions—in our webinar.
Nick McLaughlin
CEO, Breeze
We’re igniting real change. From building and accelerating revolutionary healthcare businesses to delivering transformative tech and services to our clients, we’re raising the bar of what healthcare can be.
Ready to join us?